Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)

Bibliographic Details
Main Author: Shiroma,Helio F.
Publication Date: 2015
Other Authors: Farah,Michel E., Takahashi,Walter Y., Gomes,Andre M. V., Goldbaum,Mauro, Rodrigues,Eduardo Buchele
Format: Article
Language: eng
Source: Arquivos brasileiros de oftalmologia (Online)
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000100009
Summary: Purpose: To evaluate and describe the precautions involved in the technique of intravitreal injection of antiangiogenic drugs adopted by the ophthalmologists who are members of the Brazilian Society of Retina and Vitreous (SBRV). Methods: A questionnaire containing 22 questions related to precautions taken before, during, and after intravitreal injection was sent electronically to 920 members of SBRV between November 15, 2013 and April 31, 2014. Results: 352 responses (38%) were obtained. There was a predominance of men (76%) from the southwest region of Brazil (51%). The professional experience varied between 6 and 15 years after medical specialization (50%). Most professionals (76%) performed an average of 1 to 10 intravitreal injections a week, and 88% of the procedures were performed in the operating room using povidone iodine (99%), sterile gloves, and blepharostat (94%). For inducing topical anesthesia, usage of anesthetic eye drops was the most used technique (65%). Ranibizumab (Lucentis®) was the most common drug (55%), and age-related macular degeneration (AMD) was the most treated disease (57%). Regarding the complications treated, 6% of the ophthalmologists had treated at least one case of retinal detachment, 20% had treated cases of endophthalmitis, 9% had treated cases of vitreous hemorrhage, and 12% had encountered cases of crystalline lens touch. Conclusion: Intravitreal injection is a procedure routinely performed by retina specialists and has a low incidence of complications. Performing the procedure in the operating room using an aseptic technique was preferred by most of the respondents. Ranibizumab was the most used drug, and AMD was the most treated disease.
id CBO-2_4f96ca181cc949f69cd71216ea145c56
oai_identifier_str oai:scielo:S0004-27492015000100009
network_acronym_str CBO-2
network_name_str Arquivos brasileiros de oftalmologia (Online)
repository_id_str
spelling Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)Intravitreal injectionsRetinal diseasesAngiogenesis inhibitorsTopical anesthesia Purpose: To evaluate and describe the precautions involved in the technique of intravitreal injection of antiangiogenic drugs adopted by the ophthalmologists who are members of the Brazilian Society of Retina and Vitreous (SBRV). Methods: A questionnaire containing 22 questions related to precautions taken before, during, and after intravitreal injection was sent electronically to 920 members of SBRV between November 15, 2013 and April 31, 2014. Results: 352 responses (38%) were obtained. There was a predominance of men (76%) from the southwest region of Brazil (51%). The professional experience varied between 6 and 15 years after medical specialization (50%). Most professionals (76%) performed an average of 1 to 10 intravitreal injections a week, and 88% of the procedures were performed in the operating room using povidone iodine (99%), sterile gloves, and blepharostat (94%). For inducing topical anesthesia, usage of anesthetic eye drops was the most used technique (65%). Ranibizumab (Lucentis®) was the most common drug (55%), and age-related macular degeneration (AMD) was the most treated disease (57%). Regarding the complications treated, 6% of the ophthalmologists had treated at least one case of retinal detachment, 20% had treated cases of endophthalmitis, 9% had treated cases of vitreous hemorrhage, and 12% had encountered cases of crystalline lens touch. Conclusion: Intravitreal injection is a procedure routinely performed by retina specialists and has a low incidence of complications. Performing the procedure in the operating room using an aseptic technique was preferred by most of the respondents. Ranibizumab was the most used drug, and AMD was the most treated disease. Conselho Brasileiro de Oftalmologia2015-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000100009Arquivos Brasileiros de Oftalmologia v.78 n.1 2015reponame:Arquivos brasileiros de oftalmologia (Online)instname:Conselho Brasileiro de Oftalmologia (CBO)instacron:CBO10.5935/0004-2749.20150009info:eu-repo/semantics/openAccessShiroma,Helio F.Farah,Michel E.Takahashi,Walter Y.Gomes,Andre M. V.Goldbaum,MauroRodrigues,Eduardo Bucheleeng2015-04-16T00:00:00Zoai:scielo:S0004-27492015000100009Revistahttp://aboonline.org.br/https://old.scielo.br/oai/scielo-oai.phpaboonline@cbo.com.br||abo@cbo.com.br1678-29250004-2749opendoar:2015-04-16T00:00Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)false
dc.title.none.fl_str_mv Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)
title Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)
spellingShingle Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)
Shiroma,Helio F.
Intravitreal injections
Retinal diseases
Angiogenesis inhibitors
Topical anesthesia
title_short Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)
title_full Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)
title_fullStr Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)
title_full_unstemmed Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)
title_sort Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)
author Shiroma,Helio F.
author_facet Shiroma,Helio F.
Farah,Michel E.
Takahashi,Walter Y.
Gomes,Andre M. V.
Goldbaum,Mauro
Rodrigues,Eduardo Buchele
author_role author
author2 Farah,Michel E.
Takahashi,Walter Y.
Gomes,Andre M. V.
Goldbaum,Mauro
Rodrigues,Eduardo Buchele
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Shiroma,Helio F.
Farah,Michel E.
Takahashi,Walter Y.
Gomes,Andre M. V.
Goldbaum,Mauro
Rodrigues,Eduardo Buchele
dc.subject.por.fl_str_mv Intravitreal injections
Retinal diseases
Angiogenesis inhibitors
Topical anesthesia
topic Intravitreal injections
Retinal diseases
Angiogenesis inhibitors
Topical anesthesia
description Purpose: To evaluate and describe the precautions involved in the technique of intravitreal injection of antiangiogenic drugs adopted by the ophthalmologists who are members of the Brazilian Society of Retina and Vitreous (SBRV). Methods: A questionnaire containing 22 questions related to precautions taken before, during, and after intravitreal injection was sent electronically to 920 members of SBRV between November 15, 2013 and April 31, 2014. Results: 352 responses (38%) were obtained. There was a predominance of men (76%) from the southwest region of Brazil (51%). The professional experience varied between 6 and 15 years after medical specialization (50%). Most professionals (76%) performed an average of 1 to 10 intravitreal injections a week, and 88% of the procedures were performed in the operating room using povidone iodine (99%), sterile gloves, and blepharostat (94%). For inducing topical anesthesia, usage of anesthetic eye drops was the most used technique (65%). Ranibizumab (Lucentis®) was the most common drug (55%), and age-related macular degeneration (AMD) was the most treated disease (57%). Regarding the complications treated, 6% of the ophthalmologists had treated at least one case of retinal detachment, 20% had treated cases of endophthalmitis, 9% had treated cases of vitreous hemorrhage, and 12% had encountered cases of crystalline lens touch. Conclusion: Intravitreal injection is a procedure routinely performed by retina specialists and has a low incidence of complications. Performing the procedure in the operating room using an aseptic technique was preferred by most of the respondents. Ranibizumab was the most used drug, and AMD was the most treated disease.
publishDate 2015
dc.date.none.fl_str_mv 2015-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000100009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000100009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/0004-2749.20150009
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Conselho Brasileiro de Oftalmologia
publisher.none.fl_str_mv Conselho Brasileiro de Oftalmologia
dc.source.none.fl_str_mv Arquivos Brasileiros de Oftalmologia v.78 n.1 2015
reponame:Arquivos brasileiros de oftalmologia (Online)
instname:Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
instname_str Conselho Brasileiro de Oftalmologia (CBO)
instacron_str CBO
institution CBO
reponame_str Arquivos brasileiros de oftalmologia (Online)
collection Arquivos brasileiros de oftalmologia (Online)
repository.name.fl_str_mv Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)
repository.mail.fl_str_mv aboonline@cbo.com.br||abo@cbo.com.br
_version_ 1754209028516347904